Again, the role of p53 inhibition in the tumorigenic effects by TRIM59 were not specifically investigated in colon carcinoma cells but data from gastric cancer demonstrated that TRIM59 can physically interact with p53, thereby promoting p53 ubiquitination and degradation by the proteasome (Figure 2A) [88]. Here, TP53 is linked to colon carcinoma.